RAMSAY GENERALE DE SANTE SA Pharmaceuticals, Biotechnology & Life Sciences
$0.007
30 June 2023 at 3:17pm
High
$0.01Low
$0.01Trades
6Turnover
$9,683Volume
1,383,303
RAMSAY GENERALE DE SANTE SA
Pharmaceuticals, Biotechnology & Life Sciences
Regeneus partners with Defence to treat combat casualties
RGS released this announcement to the ASX on 29 April 2021, 9:49. The announcement is marked as price sensitive, and is 2 page(s) in length and 144kb in size.
You can view all announcements from RGS and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RGS | |
|---|---|
| Ceasing to be a substantial holder | 15 June 2023, 12:45 |
| Change in substantial holding | 1 May 2023, 8:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 11:28 |
| Regeneus partners with Defence to treat combat casualties | 29 April 2021, 9:49 |
| Regeneus to be granted key Progenza patent in Europe | 16 March 2021, 8:56 |
| Regeneus Company Update Investor Webcast Presentation | 3 March 2021, 9:16 |
| Appendix 3Z Final Director's Interest Notice Dr Alan Dunton | 1 March 2021, 11:05 |
If you were already registered, log in here.
If you were already registered, log in here.